177 related articles for article (PubMed ID: 36774237)
21. Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patient.
Emmerich D; Zemojtel T; Hecht J; Krawitz P; Spielmann M; Kühnisch J; Kobus K; Osswald M; Heinrich V; Berlien P; Müller U; Mautner VF; Wimmer K; Robinson PN; Vingron M; Tinschert S; Mundlos S; Kolanczyk M
Eur J Hum Genet; 2015 Jun; 23(6):870-3. PubMed ID: 25293717
[TBL] [Abstract][Full Text] [Related]
22. Developmental abnormalities and cancer predisposition in neurofibromatosis type 1.
Larizza L; Gervasini C; Natacci F; Riva P
Curr Mol Med; 2009 Jun; 9(5):634-53. PubMed ID: 19601812
[TBL] [Abstract][Full Text] [Related]
23. Coincidental Expression of Classic Hodgkin Lymphoma and Neurofibromatosis Type I and Literature Review.
Cabrera TB; Wang W; Yedururi S; Slopis JM; Steiner RE; Rytting ME; Cuglievan B
J Pediatr Hematol Oncol; 2021 May; 43(4):e535-e538. PubMed ID: 32366782
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and NF1 gene mutation analysis of three successive generations in three different Indian families with neurofibromatosis type 1 and peripheral nerve sheath tumours.
Prasad BCM; Chandra VVR; Sudarsan A; Kumar PS; Sarma PVGK
J Clin Neurosci; 2018 Jul; 53():62-68. PubMed ID: 29680440
[TBL] [Abstract][Full Text] [Related]
25. [Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].
Wimmer K
Wien Med Wochenschr; 2005 Jun; 155(11-12):273-80. PubMed ID: 16035388
[TBL] [Abstract][Full Text] [Related]
26. Synchronous cutaneous malignant peripheral nerve sheath tumor and jejunal gastrointestinal stromal tumor and submucosal angiomyolipoma in type 1 neurofibromatosis: A case report and literature review.
Kim KJ; Kim MS; Hong R; Lim SC
Medicine (Baltimore); 2023 Jan; 102(3):e32696. PubMed ID: 36701730
[TBL] [Abstract][Full Text] [Related]
27. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
[TBL] [Abstract][Full Text] [Related]
28. Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway.
Feldkamp MM; Angelov L; Guha A
Surg Neurol; 1999 Feb; 51(2):211-8. PubMed ID: 10029430
[TBL] [Abstract][Full Text] [Related]
29. Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
Nebesio TD; Ming W; Chen S; Clegg T; Yuan J; Yang Y; Estwick SA; Li Y; Li X; Hingtgen CM; Yang FC
Glia; 2007 Apr; 55(5):527-36. PubMed ID: 17236191
[TBL] [Abstract][Full Text] [Related]
30. A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
Tong HX; Li M; Zhang Y; Zhu J; Lu WQ
Genet Mol Res; 2012 Aug; 11(3):2972-8. PubMed ID: 22869071
[TBL] [Abstract][Full Text] [Related]
31. THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1.
Lin F; Zhang D; Chang J; Tang X; Guan W; Jiang G; Zhu C; Bian F
Eur J Med Genet; 2018 Feb; 61(2):84-88. PubMed ID: 29079545
[TBL] [Abstract][Full Text] [Related]
32. [Neurofibromin - protein structure and cellular functions in the context of neurofibromatosis type I pathogenesis].
Abramowicz A; Gos M
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1331-48. PubMed ID: 26671924
[TBL] [Abstract][Full Text] [Related]
33. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
[TBL] [Abstract][Full Text] [Related]
34. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.
Klose A; Ahmadian MR; Schuelke M; Scheffzek K; Hoffmeyer S; Gewies A; Schmitz F; Kaufmann D; Peters H; Wittinghofer A; Nürnberg P
Hum Mol Genet; 1998 Aug; 7(8):1261-8. PubMed ID: 9668168
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis 1: closing the GAP between mice and men.
Dasgupta B; Gutmann DH
Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
[TBL] [Abstract][Full Text] [Related]
36. Neurological malignancies in neurofibromatosis type 1.
Eoli M; Saletti V; Finocchiaro G
Curr Opin Oncol; 2019 Nov; 31(6):554-561. PubMed ID: 31436563
[TBL] [Abstract][Full Text] [Related]
37. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
Dasgupta B; Dugan LL; Gutmann DH
J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
[TBL] [Abstract][Full Text] [Related]
38. NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies.
Ponti G; Martorana D; Pellacani G; Ruini C; Loschi P; Baccarani A; De Santis G; Pollio A; Neri TM; Mandel VD; Maiorana A; Maccio L; Maccaferri M; Tomasi A
Anticancer Res; 2014 Jun; 34(6):3021-30. PubMed ID: 24922668
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.
Laycock-van Spyk S; Thomas N; Cooper DN; Upadhyaya M
Hum Genomics; 2011 Oct; 5(6):623-90. PubMed ID: 22155606
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]